USPTO – CFN Media

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 — Clearmind Medicine…

Ryan Allway
August 1, 2023

Top News

nveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

Intellectual property describes composition of matter claims governing Enveric’s lead clinical candidate,…

Ryan Allway
May 18, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Stallion Uranium Advancing Key Targets with HeliSam Survey

VANCOUVER, British Columbia, Oct. 03, 2024 (GLOBE NEWSWIRE) — Stallion Uranium…

Ryan Allway
October 3, 2024

Legislation, Lawsuits Pushing Plastic Recycling Technology Forward

Sometimes, inadequate systems and processes become so ingrained that a major catalyst…

Ryan Allway
September 25, 2024

Lithium Offtake Agreements, Mergers Offer Opportunities

The lithium market has had a bit of a rocky year, with…

Robin Lefferts
September 24, 2024

Healthcare Stocks

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol…

Ryan Allway
September 24, 2024